Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Gastroenterology|August 26, 2018
Effects of Long-term Norfloxacin Therapy in Patients With Advanced CirrhosisRichard Moreau, Laure Elkrief, Christophe Bureau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2017
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT studySébastien Dharancy, Audrey Coilly, Claire Fougerou-Leurent, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
Journal of Hepatology|June 6, 2016
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT studyAudrey Coilly, Claire Fougerou-Leurent, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)|April 11, 2018
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver TransplantationPauline Houssel-Debry, Audrey Coilly, Claire Fougerou-Leurent, et al.
Journal of Hepatology|September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsStanislas Pol, Marc Bourliere, Sandy Lucier, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyLaurent Lam, Hélène Fontaine, Marc Bourliere, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
Pageof 6